Want to see SG:C05 full AI Analyst Report?
C05 Stock Chart & Stats
S$0.52
-S$0.02(-4.35%)
At close: 4:00 PM EST
S$0.52
-S$0.02(-4.35%)
Day’s Range― - ―
52-Week RangeS$0.47 - S$0.68
Previous CloseN/A
Volume2.90K
Average Volume (3M)17.24K
Market Cap
S$49.36M
Enterprise ValueS$23.11M
Total Cash (Recent Filing)S$20.09M
Total Debt (Recent Filing)S$2.29M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.77%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding75,945,400
10 Day Avg. Volume1,940
30 Day Avg. Volume17,243
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)0.35
Price to Sales (P/S)0.61
P/FCF Ratio29.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservatively Levered Balance SheetVery low leverage and a stable equity base provide financial flexibility, reduce refinancing risk, and improve resilience during weak operating periods. This conservative capital structure can also preserve the company’s ability to fund operations or pursue opportunities without relying heavily on additional borrowing.
Improving 2026 Cash GenerationThe return to positive operating and free cash flow is a meaningful improvement in internal funding capacity. If sustained, stronger cash conversion can support liquidity, reduce dependence on external financing, and give management greater flexibility while profitability remains under pressure.
Loss Reduction And Positive EBITDAA substantially smaller loss and positive EBITDA indicate that the severe deterioration seen in 2025 may be easing. Although earnings have not yet recovered, this improvement suggests operating cost pressure could be moderating and provides a foundation for a potential return to profitability.
Bears Say
Multi-Year Revenue DeclineSeveral years of falling revenue point to sustained pressure on demand, market position, or business scale rather than a single-quarter fluctuation. Continued contraction can reduce operating leverage, limit reinvestment capacity, and make it harder to restore durable profitability even with cost controls.
Profitability Not Re-establishedThe company remains unprofitable at the net and operating levels, so the strong capital base is not currently being converted into shareholder returns. Persistent losses can weaken retained earnings over time and constrain strategic flexibility until margins and operating income recover consistently.
Volatile Historical Cash FlowDespite positive cash flow in 2026, the uneven historical pattern makes liquidity and self-funding less predictable. Variability linked to working capital or capital spending can create periodic financing needs and reduces confidence that recent cash generation will remain durable through changing operating conditions.
Chemical Industries Far East Ltd. News
C05 FAQ
What was Chemical Industries Far East Ltd.’s price range in the past 12 months?
Chemical Industries Far East Ltd. lowest share price was S$0.47 and its highest was S$0.68 in the past 12 months.
What is Chemical Industries Far East Ltd.’s market cap?
Chemical Industries Far East Ltd.’s market cap is S$49.36M.
When is Chemical Industries Far East Ltd.’s upcoming earnings report date?
Chemical Industries Far East Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 66 days.
How were Chemical Industries Far East Ltd.’s earnings last quarter?
Chemical Industries Far East Ltd. released its earnings results on May 26, 2026. The company reported S$0.018 earnings per share for the quarter.
Is Chemical Industries Far East Ltd. overvalued?
According to Wall Street analysts Chemical Industries Far East Ltd.’s price is currently Overvalued.
Does Chemical Industries Far East Ltd. pay dividends?
Chemical Industries Far East Ltd. pays a Annually dividend of S$0.005 which represents an annual dividend yield of 0.77%. See more information on Chemical Industries Far East Ltd. dividends here
What is Chemical Industries Far East Ltd.’s EPS estimate?
Chemical Industries Far East Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chemical Industries Far East Ltd. have?
Chemical Industries Far East Ltd. has 75,945,400 shares outstanding.
What happened to Chemical Industries Far East Ltd.’s price movement after its last earnings report?
Chemical Industries Far East Ltd. reported an EPS of S$0.018 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Chemical Industries Far East Ltd.?
Currently, no hedge funds are holding shares in SG:C05
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Chemical Industries Far East Ltd.
Incorporated in Singapore in 1962, Chemical Industries (Far East) Limited functions as an investment holding entity primarily involved in the production and sale of chemicals across Singapore and Myanmar. Its operations are organized into two distinct divisions: Industrial Chemicals and Properties. Within its chemical arm, the company manufactures essential compounds such as sodium hypochlorite, chlorine, hydrochloric acid, and calcium hydroxide, vital for applications in water purification and the electronics sector. Beyond manufacturing, it also offers comprehensive distribution and logistics solutions for chemicals. Additionally, the firm oversees and leases commercial real estate. Completing its portfolio, it acts as a broad-based merchant, facilitating the import and export of a range of chemical products.
Technical Analysis
China Sunsine Chemical Holdings Ltd.
―
Matex International Limited
―
MegaChem Ltd.
―
AsiaPhos Limited
―
Jiutian Chemical Group Limited
―